pharmaceuticals

Industry

Which UK companies are the most diverse and inclusive?

Out of over 7,000 firms

clock 06 September 2018 • 1 min read

Markets

Lloyds, BP, Glaxo: Which were the top ten most bought companies in H1 2018?

Bias towards income payers

clock 17 August 2018 • 1 min read

UK

Three hidden gems in the UK small-cap sector challenging their larger peers

Pharma sector and specialist managers among picks

clock 14 August 2018 • 3 min read

Markets

Nine megatrends of the future to shape investment growth

Top nine trends to focus on

clock 31 July 2018 • 1 min read

UK

Cantor Fitzgerald's top UK stock picks for the rest of 2018

Key sectors include clean energy and technology

clock 30 July 2018 • 1 min read

UK

The 'intriguing value case' for UK equities

Investors discounting fears of slowdown

clock 20 June 2018 • 2 min read

Global

US healthcare market is too focused on the new drugs taking market share

US healthcare system largest in the world

clock 13 June 2018 • 2 min read

UK

Schroders' duo Casey and Kissack make 'wholesale changes' to UK Alpha Plus

'Style of the fund has changed dramatically'

clock 24 May 2018 • 3 min read

Specialist

Polar Capital's Pinniger: The next generation of biotech leaders

'Wobbling risk appetite'

clock 22 May 2018 • 2 min read

Emerging markets

Matthews Asia's Asnani: The outlook for India's stockmarket

Sunil Asnani, portfolio manager at Matthews Asia, gives his views on the most exciting investment opportunities in India and what lies ahead for the country in H2 2018.

clock 17 May 2018 • 5 min read
Most read
01

Baillie Gifford UK Growth trust exits Hargreaves Lansdown over 'management missteps'

29 November 2024 • 3 min read
02

Generative AI expands into investment processes but fails to replace fund managers

29 November 2024 • 4 min read
03

On the night gallery: Women in Investment Awards 2024

28 November 2024 • 1 min read
04

Investment Week reveals winners of Women in Investment Awards 2024

28 November 2024 • 4 min read
05

Jupiter's Jason Pidcock on ESG 'nonsense' and why China remains 'unappealing'

27 November 2024 • 5 min read
Trustpilot